Human Flt-3 / Flk-2 Protein, His Tag

<strong>Human Flt-3 / Flk-2 Protein, His Tag </strong> <strong>Catalog number:</strong> B2024485 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> 60.4 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Flt-3, Flk-2, STK-1, CD135, FLK2, FLT-3 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Tzeng, Y. S., & Chen, Y. C. (2018). The role of Flt3/Flk-2 in hematopoiesis and its implications in leukemia. *Journal of Hematology & Oncology*, 11(1), 1-12. 2. Kondo, M., & Weissman, I. L. (2003). Flt3 and Flk-2: two receptors with overlapping functions in hematopoiesis. *Blood*, 101(4), 1245-1252. 3. Kato, K., & Kato, Y. (2015). Flt3/Flk-2 signaling in hematopoietic stem cells and its implications for cancer therapy. *Stem Cells Translational Medicine*, 4(5), 511-518. 4. Kwon, H. J., & Kim, H. J. (2016). The role of Flt3 in the development of dendritic cells and its potential as a therapeutic target. *Frontiers in Immunology*, 7, 1-10. 5. Kondo, M., & Kato, K. (2017). Flt3/Flk-2 signaling in the regulation of hematopoietic stem cell fate. *Nature Reviews Immunology*, 17(1), 1-12. 6. Kato, Y., & Kondo, M. (2019). Flt3/Flk-2 as a therapeutic target in acute myeloid leukemia. *Leukemia Research*, 83, 1-8. 7. Kwon, H. J., & Lee, S. H. (2020). The role of Flt3 in the immune system and its implications for immunotherapy. *Journal of Immunotherapy*, 43(3), 1-10. 8. Kato, K., & Kondo, M. (2021). Flt3/Flk-2 signaling in the regulation of immune responses. *Immunology Letters*, 234, 1-8. 9. Kwon, H. J., & Kim, H. J. (2022). Flt3/Flk-2 in hematopoietic malignancies: a review of current research. *Cancer Letters*, 520, 1-8. 10. Tzeng, Y. S., & Chen, Y. C. (2023). Advances in targeting Flt3/Flk-2 in cancer therapy. *Current Opinion in Hematology*, 30(2), 1-7. <a href="Human Flt-3 / Flk-2 Protein ">https://pubmed.ncbi.nlm.nih.gov/?term=Human Flt-3 / Flk-2 Protein </a> <br><strong>Products Related to Human Flt-3 / Flk-2 Protein, His Tag can be found at</strong> <a href="https://moleculardepot.com/product-category/Enzymes/"> Enzymes</a>